In patients, APOL1 kidney disease appears to follow a two-hit model, whereby a genetic predisposition (presence of two APOL1 kidney risk alleles) is coupled with factors that increase APOL1 gene expression (interferon being the most well-documented). This evidence concerns the gene APOL1 and urogenital neoplasm.